The Role of Proteasomes in Disease

作者: Burkhardt Dahlmann

DOI: 10.2970/TPDB.2007.32

关键词:

摘要:

参考文章(157)
Toshiro Kageshita, Shunji Hirai, Tomomichi Ono, Daniel J. Hicklin, Soldano Ferrone, Down-regulation of HLA class I antigen-processing molecules in malignant melanoma: association with disease progression. American Journal of Pathology. ,vol. 154, pp. 745- 754 ,(1999) , 10.1016/S0002-9440(10)65321-7
Sherwin Wilk, Wei-Er Chen, Synthetic peptide-based activators of the proteasome Molecular Biology Reports. ,vol. 24, pp. 119- 124 ,(1997) , 10.1023/A:1006851428691
Hardy J. Rideout, Kristin E. Larsen, David Sulzer, Leonidas Stefanis, Proteasomal inhibition leads to formation of ubiquitin/α-synuclein-immunoreactive inclusions in PC12 cells Journal of Neurochemistry. ,vol. 78, pp. 899- 908 ,(2001) , 10.1046/J.1471-4159.2001.00474.X
Kyung Bo Kim, Fabiana N. Fonseca, Craig M. Crews, Development and Characterization of Proteasome Inhibitors Methods in Enzymology. ,vol. 399, pp. 585- 609 ,(2005) , 10.1016/S0076-6879(05)99039-3
Susi Keck, Robert Nitsch, Tilman Grune, Oliver Ullrich, Proteasome inhibition by paired helical filament-tau in brains of patients with Alzheimer's disease. Journal of Neurochemistry. ,vol. 85, pp. 115- 122 ,(2003) , 10.1046/J.1471-4159.2003.01642.X
Edor Kabashi, Jeffrey N. Agar, David M. Taylor, Sandra Minotti, Heather D. Durham, Focal dysfunction of the proteasome: a pathogenic factor in a mouse model of amyotrophic lateral sclerosis. Journal of Neurochemistry. ,vol. 89, pp. 1325- 1335 ,(2004) , 10.1111/J.1471-4159.2004.02453.X
Peter M. Howley, Carl G. Maki, Jon M. Huibregtse, In Vivo Ubiquitination and Proteasome-mediated Degradation of p53 Cancer Research. ,vol. 56, pp. 2649- 2654 ,(1996)